Edition:
United States

Consort Medical PLC (CSRT.L)

CSRT.L on London Stock Exchange

1,004.00GBp
20 Jan 2017
Change (% chg)

4.00 (+0.40%)
Prev Close
1,000.00
Open
999.50
Day's High
1,029.00
Day's Low
996.00
Volume
15,836
Avg. Vol
90,258
52-wk High
1,180.00
52-wk Low
935.00

Latest Key Developments (Source: Significant Developments)

Vitec says finance head Hayes to leave for Consort Medical job
Friday, 25 Nov 2016 02:00am EST 

Vitec Group Plc : Paul Hayes, group finance director, has informed board that he will be leaving Vitec to become chief financial officer of Consort Medical Plc . Paul will remain with Vitec until April 2017 .Search process to identify his successor is now underway.  Full Article

Consort Medical names Vitec finance head Paul Hayes as its next CFO
Friday, 25 Nov 2016 02:00am EST 

Consort Medical Plc :Paul Hayes, finance director of Vitec Group Plc, is to succeed Richard Cotton as Consort Medical's group chief financial officer.  Full Article

Dechra Pharma poaches finance head from Consort Medical
Wednesday, 17 Aug 2016 02:30am EDT 

Dechra Pharmaceuticals Plc : Appointment of chief financial officer .Appointment of Richard Cotton as chief financial officer.  Full Article

Consort Medical CFO resigns to join Dechra Pharma
Wednesday, 17 Aug 2016 02:00am EDT 

Consort Medical Plc : Says Richard Cotton, group chief financial officer will be leaving business after interim results in Dec. 2016 .Says will be leaving business in order to accept position of chief financial officer at Dechra Pharmaceuticals Plc.  Full Article

Consort Medical Plc proposes final dividend
Tuesday, 16 Jun 2015 02:00am EDT 

Consort Medical Plc:Is proposing an unchanged final dividend of 11.68 pence (FY2014: 11.68 pence), making a total dividend for the year of 18.11 pence (FY2014: 18.11 pence).  Full Article

Consort Medical announces integrated dose counter supply agreement
Wednesday, 4 Feb 2015 02:00am EST 

Consort Medical Plc:Says the conclusion of a new commercial supply agreement for its integrated dose counter (IDC) system.Multi-year supply agreement covers supply of both the IDC actuator and the pressurised metered dose inhaler (pMDI) valve.IDC programme represents the first commercial oral variant of the device, which is already approved and marketed for a nasally delivered product.  Full Article

BRIEF-Vitec says finance head Hayes to leave for Consort Medical job

* Paul Hayes, group finance director, has informed board that he will be leaving Vitec to become chief financial officer of Consort Medical Plc